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STRUCTURED ABSTRACT  
PURPOSE OF REVIEW: We present a current perspective of epigenetic alterations that can 
lead to cardiovascular disease (CVD) and the potential of dietary factors to counteract their 
actions. In addition, we discuss the challenges and opportunities of dietary treatments as 
epigenetic modifiers for disease prevention and therapy.  
RECENT FINDINGS: Recent epigenome-wide association studies along with candidate gene 
approaches and functional studies in cell culture and animal models have delineated mechanisms 
through which nutrients, food compounds and dietary patterns may affect the epigenome. Several 
risk factors for CVD, including adiposity, inflammation and oxidative stress have been associated 
with changes in histone acetylation, lower global DNA methylation levels and shorter telomere 
length. A surplus of macronutrients such as in a high fat diet or deficiencies of specific nutrients 
such as folate and B-vitamins can affect the activity of DNA methyltransferases and histone 
modifying enzymes, affecting foetal growth, glucose/lipid metabolism, oxidative stress, 
inflammation and atherosclerosis. Bioactive compounds such as polyphenols (resveratrol, 
curcumin) or epigallocatechin may activate deacetylases SIRTs, histone deacetylases or 
acetyltransferases and in turn the response of inflammatory mediators. Adherence to 
cardioprotective dietary patterns, such as the Mediterranean diet (MedDiet), has been associated 
with altered methylation and expression of genes related to inflammation and immuno-
competence. 
SUMMARY: The mechanisms through which nutrients and dietary patterns may alter the 
cardiovascular epigenome remain elusive. The research challenge is to determine which of these 
nutriepigenetic effects are reversible, so that novel findings translate into effective dietary 
interventions to prevent CVD or its progression. 
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Cardiovascular disease (CVD) is a major global cause of morbidity and mortality [1], whose 
prevalence is predicted to further increase in both developing and developed countries [2]. The 
pathophysiology of CVD is characterised by endothelial dysfunction, vascular inflammation, 
atherosclerosis, fibrosis and thrombosis, with multiple pathways simultaneously perturbed [3]. 
The progressive remodelling and loss of flexibility that occurs during ageing of the vasculature 
contributes to the onset of CVD. Telomere attrition, epigenetic alterations and mitochondrial 
dysfunction are, among others, hallmarks of molecular damage that accumulate during ageing [4]. 
Many environmental factors that lead to CVD are mediated by epigenetic changes, which include 
posttranslational modifications to histone tails of nucleosomes (such as methylation, acetylation 
and phosphorylation), DNA methylation and non-coding RNA regulation of chromatin 
remodelling [5]. The role of diet and physical activity on CVD outcomes has been extensively 
studied [6][7], but evidence for the mechanisms by which dietary components might manipulate 
the epigenome of ageing vascular cells reversibly, perhaps, remains poor.  
Mitochondria: a cellular powerhouse of epigenetic modifiers 
Epigenetics describes the reversible and heritable changes in genes, which alter gene functions 
without affecting the DNA sequence [5]. A key component of the effect of the epigenome on 
gene expression is the assembly of DNA and proteins into chromatin. Genomic DNA in 
eukaryotic cells is wrapped around histone proteins to form nucleosomes, which comprise the 
basic building blocks of chromatin [8]. Various post-translational modifications of the histones 
affect its 3D-structure and lead either to exposure of DNA, which makes it accessible to the 
transcriptional machinery, or have the opposite effect, which results in gene silencing. In addition 
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to their primary role as the cellular ATP producers, mitochondria constitute the platform where 
most of the epigenetic modifiers or other metabolites that affect epigenetic modifications are 
formed [8]. Thus, changes in mitochondrial function are closely associated with availability of 
epigenetic modifiers (Figure 1).  
Histone acetylation – Acetyl-CoA is used as an acetyl group donor by histone acetyltransferases 
(ΗΑΤ), which mediate acetylation of nucleosomal histones, chromatin remodeling and activation 
of gene transcription. Acetyl-CoA is the main donor for acetylation of chromatin and of proteins 
involved in nDNA transcription and replication [8]. It is formed in mitochondria from glycolysis 
(catabolism of pyruvate)  or from β-oxidation of fatty acids. De-acetylation of chromatin by 
histone deacetylases (HDACs) leads to transcriptional repression. Sirtuins (SIRTs) are class III 
HDACs that couple lysine deacetylation to NAD+ hydrolysis and lead to formation of 
nicotinamide, which signals back to SIRTs by inhibiting their activity [5]. Thus, the levels of 
NAD+, NADH or NAM affect SIRT-mediated deacetylation of chromatin. NAD+, which is 
formed in mitochondria, is an obligatory cofactor for the activity of SIRT1, SIRT6 and SIRT7. 
Histone and DNA methylation - S-adenosylmethionine (SAM) is the methyl group donor for 
both histone methyltransferases (HMTs) and DNA methyltransferases (DNMTs) generated by 
methionine and ATP, which is formed in mitochondria. Methylation of lysine, arginine or 
histidine of histones has been associated with both repression and activation of transcription. On 
the other hand, DNA methylation of cytosine residues in CpG dinucleotides (CpG sites) is a 
repressive gene regulation mechanism, regulating chromatin architecture and gene transcription 
[9]. S-adenosyl homocysteine (SAH), which is formed following demethylation of SAM, 
functions as a repressor of both DNMTs and histone lysine demethylases (KDMs).  
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Histone phosphorylation – ATP is critical for phosphorylation of core histones that affects gene 
expression, as well as cell division and DNA damage repair. Phosphorylation of histones 
promotes chromatin condensation, which happens during apoptosis, DNA fragmentation, and cell 
death [10]. 
Other chromatin modifications – Mass spectrometry analyses have identified additional non-
acetyl histone acylations with hydrophobic (propionylation, crotonylation butyrylation), polar (2-
hydroxyisobutyrylation and β-hydroxybutyrylation) or acidic (succinylation, malonylation, 
glutarylation) modifiers [11]. Histone propionylation, crotonylation, butyrylation, 2-
hydroxyisobutyrylation, β-hydroxybutyrylation, and succinylation have been associated with 
increased transcription (Figure 1). On the other hand, the effect of malonylation and glutarylation 
on gene transcription remains elusive. Availability of non-acetyl epigenetic modifiers is regulated 
by synthesis of short chain fatty acids, which is mediated by Acyl-CoA synthetase short-chain 
family member 2 (ACSS2) that are eventually oxidized and provide the acyl modifiers. 
Ketogenesis, a mitochondrial process that occurs in response to low blood glucose and hepatic 
glycogen, accounts for the formation of β-hydroxybutyrate. 
The expression levels of many of the enzymes that are involved in acetylation and methylation 
processes, along with the impact of genetic changes, such as single nucleotide polymorphisms 
(SNPs), represent components of an interactive network that orchestrates changes in chromatin 
structure [8]. In that context, cellular metabolic functions that generate ATP, acetyl-CoA, NADH 
and ROS from carbohydrates and fats drive a range of epigenetic modifications. 
The epigenome and cardiovascular disease 
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The interrelationship between subendothelial accumulation of apo-B containing lipoproteins and 
inflammation is central for the pathogenesis of atherosclerosis [3]. The association of 
inflammatory markers (IL6, IL1β , IL8, high-sensitivity C-reactive protein, vascular cell adhesion 
molecule-1) and dyslipidaemias with DNA methylation in CVD has been recently reviewed [12]. 
Epigenetic changes affect endothelial function, vasomotor tone, cytokine signaling and fibrosis at 
the site of plaque formation [6][13]. Hypomethylation of genomic DNA, which is generally 
associated with increased gene expression, has been observed in several tissues, including 
vascular smooth-muscle cells, atherosclerotic lesions and peripheral blood leukocytes, of patients 
with atherosclerosis [14]. Muka et al. [13] looked at studies that examined DNA methylation of 
CpG sites in or near CVD-related genes. They reported that lower levels of methylation at long-
interspersed nuclear elements (LINE-1), a surrogate for global genomic DNA methylation levels), 
and higher methylation of Alu repeats were inversely associated with CVD risk, independent of 
established cardiovascular risk factors [13]. In addition, altered methylation patterns were found 
in genes involved in foetal growth, glucose/lipid metabolism, oxidative stress, inflammation and 
atherosclerosis in blood cells related with CVD [13].  
A recent epigenome-wide association study (EWAS) in Japanese individuals reported that 10 
CpG sites were hypermethylated and 16 hypomethylated in genomic DNA extracted from the 
aortic intima of atheromatous plaque lesions compared to control plaque-free intima [15]. One of 
the hypermethylated CpG sites was located in the long non-coding HOX transcript antisense 
RNA (HOTAIR) gene, which may be activated by thymic stromal lymphopoietin (TSLP), a 
vascular smooth muscle cell protein with anti-inflammatory and anti-oxidant effects [16]. Some 
of the hypomethylated sites were in genes encoding proteins in the Wnt signaling pathway, which 
is known to be involved in atherosclerosis [17]. Individuals with established CVD have higher 
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promoter methylation levels of various metabolism-related genes including those that encode 
metalloproteinases, gene products involved in homocysteine and one carbon-metabolism and in 
ATP production [13]. In population cohorts from Sweden [18] and Japan [19], EWAS have found 
differential DNA methylation at individual CpG sites (211 sites vs 3 sites respectively) to be 
independently associated with MI risk. However, these studies were carried out using DNA from 
peripheral blood mononuclear cells (PBMCs) due to the practical difficulties in obtaining 
myocardium or blood vessel wall biopsies, so their relevance to cardiac cell function remains to 
be established.  
There are only few studies associating histone modifications with CVD risk or disease 
mechanisms. A review of animal and cell studies concluded that histone acetylation in endothelial 
cells can either prevent (c-jun) or induce (RNAP II) transcription factor binding or specificity 
[20]. Other chromatin-modifying enzymes may affect transcription factor recruitment. A recent in 
vivo study in human hearts reported that during postnatal development there is a fine cooperation 
of active CpG methylation and histone marks in regions enriched for CVD-associated variants to 
shape the cardiomyocyte transcriptome [21]. In contrast, when cardiomyocytes from failing 
hearts were compared to those from non-failing hearts, active histone marks of several 
pathological genes were affected, including connective tissue growth factor (CTGF) and 
natriuretic peptides A and B (NPPA, NPPB), while CpG methylation was stable [21]. 
Telomeres 
Telomeres are nucleoprotein structures that protect the ends of linear chromosomes from DNA 
degradation and fusion. Vertebrate telomeres are composed of multiple copies of the sequence 
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TTAGGG bound to the protein complex shelterin [22]. Highly heterochromatic, heavily 
methylated adjacent regions called subtelomeres also help to preserve telomere integrity [23].  
In most somatic tissues, telomeres become shorter with every cell division; a process accelerated 
by oxidative stress [23]. Chronic inflammation is presumed to shorten telomeres in leukocytes, 
due to increased cell turnover. Thus, in addition to mitochondrial dysfunction, dysregulated 
nutrient sensing and epigenetic alterations, telomere length is a well-established ‘hallmark’ of 
cellular ageing [4]. Mean leukocyte telomere length (LTL) is an independent predictor of several 
age-related conditions, including coronary heart disease and other forms of CVD [24]. 
Furthermore, recent studies suggest that in addition to telomere length, the integrity of telomeres 
decreases with age and with development of hypertension in vascular tissue [25]. 
Diet as an epigenetic intervention point in cardiovascular disease 
Most metabolic pathways affect a range of cellular functions and often act as a network, with a 
single gene product affecting several distant parts of a pathway. Thus, it becomes difficult to 
identify particular targets for epigenetic interventions. Additional challenges are the identification 
of direct epigenetic effects of any single dietary component and the inability of epigenetic 
biomarkers to distinguish between causal, consequential and coincidental relationships. With 
these caveats, dietary components associated with particular exposures and epigenetic changes 
are reviewed below, in an effort to identify potential intervention points. 
One of the important factors to consider is the timing of epigenetic alterations triggered by dietary 
factors which often defines the magnitude of the epigenetic impact, such as in the case of 
nutritional deficiencies being critical during early gestation [26]. An example is folate deficiency, 
which when corrected preconceptually can prevent neural tube defects, but has no effect if given 
 
11 
after the first trimester of pregnancy, as the development and closure of the neural tube is 
completed 28 days after conception [27]. The persistence of the epigenetic phenotype for more 
than a few generations was observed early on in malnourished animals [28]. The associations 
between epigenetic perturbations in utero, maternal dietary changes and developmental 
programming of CVD has been previously reviewed [29].   
Human studies of dietary effects on the cardiovascular epigenome come from ‘natural’ 
experiments in populations of mothers and babies conceived or born during famine periods. 
These include investigations carried out in the Dutch Famine birth cohort [30] and studies in the 
Gambia, where pregnant women in rural areas experience seasonal nutritional changes due to 
weather conditions [31]. New data from the Dutch Famine birth cohort reveals that prenatal 
famine exposure during early gestation is associated with higher risk for CAD and hypertension 
in adulthood, and with altered DNA methylation within the INSR and CPT1A loci, which encode 
proteins involved in prenatal growth and fatty acid oxidation, respectively [26].  
Macronutrients - Nutrient excess has been causally linked to the pathogenesis of CVD, 
metabolic syndrome and insulin resistance [7]. Chronic carbohydrate and lipid excess may 
elevate acetyl-CoA, which changes chromatin structure, increases acetylation of DNA-binding 
proteins, suppresses autophagy and accelerates age-associated pathologies [11]. Circulating fatty 
acids such as α-linolenic acid, EPA and DHA affect changes in DNA methylation sites for genes 
such as APOE, IL6 and ABCA1 which are correlated with CVD traits [12]. Two recent human 
studies reported that obese participants had an increased CpG-methylation and reduced 
expression of PLIN1 [32] which facilitates among others lipolysis of triglycerides (TG) and, in a 
genome-wide methylation study, hypermethylation of PPARG, HAND2, HOXC6, SORBS2, 
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CD36, and CLDN1 gene promoters which may be associated with reduced adipogenesis, 
impaired triglyceride uptake and insulin sensitivity [33].  
Obesogenic high-fat diets in experimental animals were also associated with increased DNA 
methylation in the Leptin and PPARG2 gene promoters [34]. In a recent clinical trial, overfeeding 
by high-fat diets independent of the fat composition (saturated or polyunsaturated fat) increased 
DNA methylation in adipose tissue, especially in promoter regions affecting adipocyte 
differentiation, lipid metabolism, and adipose tissue expandability pathways [35]. Interestingly, 
overfeeding with saturated fatty acids changed the mean methylation of a set of proinflammatory 
signals (eg. FTO, IL6, POMC) which were different from the ones triggered by polyunsaturated 
fatty acids (eg. ADIPOQ) [35].  Furthermore, Hussay et al. [36] reviewed the inconclusive 
evidence on the effects of ω-3 fatty acids supplementation on DNA methylation, pointing out that 
males and females not only metabolise and store ω-3 fatty acids in a different way, but they also 
differ in their global DNA methylation patterns.  
In vascular and inflammatory cells, hyperglycaemia leads to chromatin changes, which in turn 
affect gene transcription [37]. In an attempt to integrate genetic (GWAS) and epigenetic (EWAS) 
data, the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study researchers 
challenged study participants with a high-fat meal and compared changes in plasma concentration 
of 35 fatty acids and 11 sterols in the fasting and postprandial state [38]. The authors proposed 
that integration of clinical data with genomic and epigenomic data on sterols and fatty acids may 
lead to identification of novel CVD biomarkers [38]. Postprandial TG responses to a high-fat 
dietary challenge increased methylation at sites of genes such as APOA5, SREBF1 and ABCG1 
that regulate lipogenesis and lipoprotein metabolism, while it lowered methylation of CPT1A [39] 
which promotes hepatic fatty acid β-oxidation. These findings were supported by other cohorts 
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(KORA and InCHIANTI), which reported in two European populations that newly identified loci 
associated with methylation of four CpG sites in CPT1A, APOA5, SREBF1, and ABCG1 might 
regulate disturbed blood lipid levels and thus contribute to the development of complex lipid-
related diseases [40][41].  
Fasting conditions have the opposite effect to overnutrition. In mouse hepatoma cells, depletion 
of glucose and/or amino acids from culture media led to increased DNA methylation and 
chromatin accessibility at the transcription start site of SIRT genes [42]. Similar to starvation and 
fasting, caloric restriction has been linked to a reduced risk of a cardiovascular disease [43], 
possibly due to its effect on weight and adiposity. A recent animal study that attempted to 
investigate the relationship between caloric restriction, lipid metabolism and vascular risk 
reported some transient beneficial effects on total cholesterol, HDL, and TG levels without any 
effect on DNA methylation patterns [44]. 
Folic acid, B-vitamins, other methyl donors - The epigenetic effects of “methyl-donor” nutrients 
on vascular ageing and cardiometabolic risk, are better understood. Dietary intake of methyl-
group donors and co-factors during pregnancy has been reported to affect foetal growth and 
development, thus establishing a major link between early environmental exposure and chronic 
disease development in the offspring later in life [45][46]. Dietary methyl-groups derived from 
methionine, choline/betaine and methyl/folate/vitamin B12 directly influence DNA and histone 
methylases, as they are the precursors leading to the formation of SAM [47]. Pauwels et al. [48] 
reported that maternal dietary and supplemental intake of methyl-group donors, in the 
periconception period only, increased infant buccal DNA methylation in genes related to growth 




Dietary intake of carotenoids and B-vitamins has been associated with longer telomeres [49][50], 
which are linked with lower CVD risk [51]. A recent prospective study reported longer LTL and 
reduced LINE-1 methylation accompanied by higher SAM in elderly subjects after one year of 
supplementation with B-vitamins [52]. In contrast, shorter LTL is associated with lower levels of 
folate, both in adults and in newborns [53]. The underlying mechanism is currently unknown, 
although a decrease in DNA methylation of the subtelomeres and subsequent loss of telomere 
integrity is one plausible explanation. The increased incorporation of uracil into the telomeric 
sequence itself may also account for the observed changes, since the conversion of dUMP to 
dTTP requires folate. This could compromise shelterin binding, affect histone methylation, or 
lead to repeated telomere breakages [22].  
Bioactive compounds - Polyphenols including flavonoids, curcuminoids, and stilbenes contained 
in fruits, vegetables, and other dietary components including green tea, red wine, and cocoa 
compose the largest ubiquitous group of bioactive compounds with well-documented anti-
inflammatory and cardioprotective actions [7]. Several studies have confirmed their beneficial 
effects on vascular structure and function, inflammation and multiple cardiovascular risk factors 
[54]. Their effects on the epigenome have been studied extensively in the cancer field, but their 
role in the “cardiovascular epigenome” is still largely unexplored. In a recent in vitro study, cocoa 
polyphenols down-regulated key genes involved in the epigenetic process (DNMTs, MTHFR and 
MTRR) of PBMCs [55]. Studies on resveratrol, a polyphenol found in grapes, berries, peanuts 
and red wine, have shown that it affects chromatin segregation [56] but it also has the capacity to 
activate the deacetylases SIRTs [57]. This affects high-glucose-induced cardiac oxidative stress, 
mitochondrial dysfunction, myocardial fibrosis and vascular ageing. A recent trial on PBMCs of 
type 2 diabetes patients reported that boosting SIRT-1 expression with resveratrol supplements 
lowered H3K56ac levels and alleviated oxidative stress [58].  
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Cruciferous vegetables are rich in the anti-inflammatory isothiocyanate sulforaphane, which 
suppresses NF-κB signalling, as well as TNF-α-induced monocyte adhesion, circulating adhesion 
molecules and chemokines in C57BL/6 mice [59]. Though cancer studies showed that 
sulforaphane downregulates histone deacetylase activity directly and affects methylation 
indirectly [60], its role on epigenetics of vascular disease has not been explored.  
The epigenetic effects of other bioactive compounds have been explored sparsely in a few recent 
cell culture and animal studies. In spontaneously hypertensive rats, dietary curcumin, the 
principal curcuminoid of turmeric and member of the ginger family, suppressed degradation of 
extracellular matrix following abnormal changes in vasomotor tone [61]. The animals fed 
curcumin also demonstrated decreased expression levels of HDAC1, and of the inflammatory 
markers matrix metalloproteinase-2 (MMP-2) and transforming growth factor β (TGFβ) in their 
coronary arteries, as well as TIMP1 transcription activation by increasing histone H3 acetylation 
at its promoter [61]. Similarly, epigallocatechin-3-gallate (EGCG), found in green tea, has been 
recognised as a histone acetyltransferase inhibitor [55]. In endothelial cells, in vitro EGCG 
induced hypoacetylation of H3 and suppressed HDAC1 expression and blocked the response of 
inflammatory mediators [62]. 
Thus, a wide range of dietary factors may alter epigenetic signatures. However, whether these 
changes play a causative role in CVD or can be used as biomarkers for early prevention and 
interventions remains to be clarified.  
Dietary patterns – In recent years, nutrition epidemiology studies have used dietary patterns 
instead of isolated nutrients as a more accurate tool to study eating habits. Among the dietary 
patterns, dietary patterns rich in fruits and vegetables as well as the Mediterranean diet (MedDiet) 
rich in olive oil, legumes, fruits and vegetables [63], have been associated with longer LTL [64] 
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and with lower risk of CVD incidence and mortality, including CHD and MI [65]. Higher 
adherence to the diet protects from hypertension, inflammation and other complications related to 
excessive adiposity and epigenetic modifications may mediate some of these effects. Adherence 
to MedDiet in a subset of the PREDIMED-Navarra study was associated with methylation and 
thus suppression of the expression of eight genes related to inflammation and 
immunocompetence [66]. However, further longitudinal studies and randomised controlled trials 
are needed before firm conclusions can be drawn regarding the causal direction of the 
relationships between dietary patterns, epigenetic changes, telomere length and disease risk.  
CONCLUSION 
Recent advances in study design combined with novel dietary assessment methods, high 
throughput technologies, and big data analytics are contributing to the development of the field of 
nutritional epidemiology, which will be invaluable in furthering our understanding of the 
relationship between diet and cardiovascular health. Epigenetics and epigenomics research can 
help to identify novel causal biomarkers. Dietary patterns that favour cardiovascular health, such 
as the MedDiet, are based on the combined action of meals high in antioxidant- and anti-
inflammatory- compounds and on olive oil, a rich source of monounsaturated fats. However, the 
MedDiet is more than just a diet. One of its significant components is a lifestyle characterised by 
frequent social interactions and associated positive effects on mood - factors that are well 
recognised to modulate disease outcomes. The extent to which pathological epigenetic changes 
can be prevented or manipulated by dietary factors in order to prevent human cardiovascular 
disease remains to be established. However, the exploration of this novel field represents a rich 




• Epigenetic alterations help elucidate the mechanisms by which diet and nutrients may 
affect gene expression and regulation. Dysregulation of the epigenome, including changes 
in DNA methylation and histone acetylation, plays a major role in CVD. 
• A surplus of macronutrients (fatty acids and carbohydrates) or nutrient deficiencies (folate 
and B-vitamins), as well as bioactive compounds such as polyphenols (resveratrol, 
curcumin) or epigallocatechin may affect the expression levels of methylation and 
acetylation enzymes and thus affect the expression of genes that are linked to vascular 
dysfunction.  
• Identification of the causal directions of the relationships between dietary patterns, 
epigenetic changes, telomere length and disease risk will facilitate the development of 
treatment and intervention measures. 
ACKNOWLEDGEMENTS 
All authors contributed in writing and editing the manuscript and generating the figures. They all 
proofread the manuscript. 
FINANCIAL SUPPORT AND SPONSORSHIP: A. Z. Kalea received support by the British 
Heart Foundation (BHF) as a chair scholar and from NIHR UCLH BRC Cardiometabolic 
Programme; K. Drosatos was supported by the National Heart, Lung and Blood Institute (NIH-
HL130218) and the W.W. Smith Charitable Trust. 
CONFLICTS OF INTEREST: The authors declare no competing financial interests in relation 




1. World Health Organization. WHO Cardiovascular Disease Facts Sheet [Internet]. 
Available from: http://www.who.int/mediacentre/factsheets/fs317/en/ 
2. Vasan RS, Benjamin EJ. The Future of Cardiovascular Epidemiology: Table. Circulation. 
2016;133(25):2626–33.  3. Tabas I. 2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular 
Mechanisms in the Progression of Atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 
2017; 37(2): 183–189. 
•  Great paper on the latest research on the natural progression of atherosclerosis 
and its link with inflammation 
4. López-Otín C, Blasco MA, Partridge L et al. The Hallmarks of Aging. Cell 2013; 153(6): 
1194–1217.  
5. Corella D, Ordovas JM. Basic Concepts in Molecular Biology Related to Genetics and 
Epigenetics. Rev Espanola Cardiol Engl Ed. 2017 ;70(9):744–53.  
• A general perspective on the basic concepts of molecular biology related to epigenetics 
6. Wallace RG, Twomey LC, Custaud M-A et al. The role of epigenetics in cardiovascular 
health and ageing: A focus on physical activity and nutrition. Mech Ageing Dev 
[Internet]. 2017 Nov; Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S0047637417302336 
• A review on lifestyle factors linked to epigenetic mechanisms pre-disposing 
individuals to cardiovascular disease 
7. Bowen KJ, Sullivan VK, Kris-Etherton PM, Petersen KS. Nutrition and Cardiovascular 
Disease—an Update. Curr Atheroscler Rep [Internet]. 2018; 20(2):8 Available from: 
http://link.springer.com/10.1007/s11883-018-0704-3 
   Updated review on the links between nutritional factors and CVD 
8. Aon MA, Cortassa S, Juhaszova M, Sollott SJ. Mitochondrial health, the epigenome and 
healthspan. Clin Sci Lond Engl 1979. 2016;130(15):1285–305.  
9. Edwards JR, Yarychkivska O, Boulard M, Bestor TH. DNA methylation and DNA 
methyltransferases. Epigenetics & Chromatin. 2017;10(1). Available from: 
http://epigeneticsandchromatin.biomedcentral.com/articles/10.1186/s13072-017-0130-8 
10. Tessarz P, Kouzarides T. Histone core modifications regulating nucleosome structure and 
dynamics. Nat Rev Mol Cell Biol. 2014;15(11):703–8.  
11. Costello KR, Schones DE. Chromatin modifications in metabolic disease: Potential 
mediators of long-term disease risk. Wiley Interdiscip Rev Syst Biol Med. 2018; 
25;e1416.  
12. Ma Y and Ordovas JM. The integration of epigenetics and genetics in nutrition research 
for CVD risk factors. Proc Nutr Soc 2017; 76(3): 333–346. 
•   A review on integration of genomic and epigenomic data in nutrition research as 
related to CVD 
13. Muka T, Koromani F, Portilla E et al. The role of epigenetic modifications in 
cardiovascular disease: A systematic review. Int J Cardiol. 2016;212:174–83.  




14. Findeisen HM, Kahles FK, Bruemmer D. Epigenetic regulation of vascular smooth 
muscle cell function in atherosclerosis. Curr Atheroscler Rep. 2013;15(5):319.  
15. Yamada Y, Horibe H, Oguri M et al. Identification of novel hyper- or hypomethylated 
CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide 
association study. Int J Mol Med 2018;41(5):2724-2732 
16. Peng Y, Meng K, Jiang L et al. Thymic stromal lymphopoietin-induced HOTAIR 
activation promotes endothelial cell proliferation and migration in atherosclerosis. Biosci 
Rep. 2017;37(4):BSR20170351.  
17. Albanese I, Khan K, Barratt B, Al‐Kindi H, Schwertani A. Atherosclerotic Calcification: 
Wnt Is the Hint. J Am Heart Assoc. 2018;7(4):e007356.  
18. Rask-Andersen M, Martinsson D, Ahsan M et al. Epigenome-wide association study 
reveals differential DNA methylation in individuals with a history of myocardial 
infarction. Hum Mol Genet. 2016;ddw302.  
19. Nakatochi M, Ichihara S, Yamamoto K et al. Epigenome-wide association of myocardial 
infarction with DNA methylation sites at loci related to cardiovascular disease. Clin 
Epigenetics [Internet]. 2017;9(1). 2017 May15;9:54.  
• Epigenome-wide association study on CVD 
20.  Bauer AJ, Martin KA. Coordinating Regulation of Gene Expression in Cardiovascular 
Disease: Interactions between Chromatin Modifiers and Transcription Factors. Front 
Cardiovasc Med 2017 Apr 6;4:19. doi: 10.3389/fcvm.2017.00019. eCollection 2017. 
21. Gilsbach R, Schwaderer M, Preissl S et al. Distinct epigenetic programs regulate cardiac 
myocyte development and disease in the human heart in vivo. Nat Commun 2018 Jan 
26;9(1):391. doi: 10.1038/s41467-017-02762-z. 
22. Pisano S, Gilson E, Giraud-Panis M-J. Dynamics under the Telomeric Bridge. Mol Cell. 
2017;68(4):643–4. 
23. Lewinska A, Adamczyk-Grochala J, Kwasniewicz E, Wnuk M. Downregulation of 
methyltransferase Dnmt2 results in condition-dependent telomere shortening and 
senescence or apoptosis in mouse fibroblasts. J Cell Physiol. 2017;232(12):3714–26 
24. D’Mello MJJ, Ross SA, Briel M et al. Association between shortened leukocyte telomere 
length and cardiometabolic outcomes: systematic review and meta-analysis. Circ 
Cardiovasc Genet. 2015;8(1):82–90. 
25. Morgan RG, Donato AJ, Walker AE. Telomere uncapping and vascular aging. Am J 
Physiol Heart Circ Physiol. 2018 Mar 16. doi: 10.1152/ajpheart.00008.2018 
26. Tobi EW, Goeman JJ, Monajemi R et al. DNA methylation signatures link prenatal 
famine exposure to growth and metabolism. Nat Commun. 2014;5:5592.  
• New analysis from the Dutch Hunger Winter cohort 
27. Haider BA, Bhutta ZA. Multiple-micronutrient supplementation for women during 
pregnancy. Cochrane Pregnancy and Childbirth Group, editor. Cochrane Database Syst 
Rev [Internet]. 2017 Apr 13;4:CD004905 
28. Stewart RJ, Sheppard H, Preece R, Waterlow JC, The effect of rehabilitation at different 
stages of development of rats marginally malnourished for ten to twelve generations. Br J 
Nutr 1980; 43(3): 403–412. 
29. Sun C, Burgner DP, Ponsonby A-L et al. Effects of early-life environment and epigenetics 




30. Painter RC, de Rooij SR, Bossuyt PM et al. Early onset of coronary artery disease after 
prenatal exposure to the Dutch famine. Am J Clin Nutr. 2006;84(2):322–7. 
31. Moore SE. Early life nutritional programming of health and disease in The Gambia. J Dev 
Orig Health Dis. 2016;7(2):123–31.  
32. Bialesova L, Kulyté A, Petrus P et al. Epigenetic Regulation of PLIN 1 in Obese Women 
and its Relation to Lipolysis. Sci Rep 2017; 7(1):10152. doi: 10.1038/s41598-017-09232-
y. 
33. Keller M, Hopp L, Liu X et al. Genome-wide DNA promoter methylation and 
transcriptome analysis in human adipose tissue unravels novel candidate genes for 
obesity. Mol Metab. 2017;6(1):86–100. 
34. Zwamborn RAJ, Slieker RC, Mulder PCA et al. Prolonged high-fat diet induces gradual 
and fat depot-specific DNA methylation changes in adult mice. Sci Rep. 2017;7:43261.  
35. Perfilyev A, Dahlman I, Gillberg L et al. Impact of polyunsaturated and saturated fat 
overfeeding on the DNA-methylation pattern in human adipose tissue: a randomized 
controlled trial. Am J Clin Nutr. 2017;105(4):991–1000.  
• RCT on the epigenetic effects of different types of dietary fatty acids 
36. Hussey B, Lindley MR, Mastana SS. Omega 3 fatty acids, inflammation and DNA 
methylation: an overview. Clin Lipidol. 2017;12(1):24–32. 
• Updated review discussing the limitations of nutriepigenetic studies with omega-3  
37. Block T, El-Osta A. Epigenetic programming, early life nutrition and the risk of metabolic 
disease. Atherosclerosis. 2017;266:31–40.  
38. Irvin MR, Zhi D, Aslibekyan S et al. Genomics of Post-Prandial Lipidomic Phenotypes in 
the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study. PLoS ONE. 
2014;9(6):e99509. 
39. Lai C-Q, Wojczynski MK, Parnell LD et al. Epigenome-wide association study of 
triglyceride postprandial responses to a high-fat dietary challenge. J Lipid Res. 
2016;57(12):2200–7.  
40. Irvin MR, Zhi D, Joehanes R et al. Epigenome-Wide Association Study of Fasting Blood 
Lipids in the Genetics of Lipid-Lowering Drugs and Diet Network Study. Circulation. 
2014;130(7):565–72.  
•  Intervention study integrating genome-wide and epigenome-wide data  
41. Pfeiffer L, Wahl S, Pilling LC et al. DNA methylation of lipid-related genes affects blood 
lipid levels. Circ Cardiovasc Genet. 2015;8(2):334–42. 
42. Zullo A, Simone E, Grimaldi M et al. Effect of nutrient deprivation on the expression and 
the epigenetic signature of sirtuin genes. Nutr Metab Cardiovasc Dis. 2018;28(4):418–24.  
43. Weiss EP, Albert SG, Reeds DN et al. Effects of matched weight loss from calorie 
restriction, exercise, or both on cardiovascular disease risk factors: a randomized 
intervention trial. Am J Clin Nutr. 2016;104(3):576–86.  
44. Nowacka-Woszuk J, Madeja ZE, Chmurzynska A. Prenatal caloric restriction alters lipid 
metabolism but not hepatic Fasn gene expression and methylation profiles in rats. BMC 
Genet [Internet]. 2017 Dec;18(1).  
45. Franke K, Gaser C, de Rooij SR, Schwab M, Roseboom TJ. Premature brain aging in 




46. Van Dijk SJ, Zhou J, Peters TJ et al. Effect of prenatal DHA supplementation on the 
infant epigenome: results from a randomized controlled trial. Clin Epigenetics. 
2016;8:114.  
47. Zeisel S. Choline, Other Methyl-Donors and Epigenetics. Nutrients. 2017;9(12):445.  
48. Pauwels S, Ghosh M, Duca RC et al. Maternal intake of methyl-group donors affects 
DNA methylation of metabolic genes in infants. Clin Epigenetics 2017 Feb 7;9:16 
49. Min K-B, Min J-Y. Association between leukocyte telomere length and serum carotenoid 
in US adults. Eur J Nutr. 2017;56(3):1045–52.  
50. Mazidi M, Kengne A-P, Banach M. Mineral and vitamin consumption and telomere 
length among adults in the United States. Pol Arch Intern Med. 2017;127(2):87–90.  
51. Baragetti A, Palmen J, Garlaschelli K et al. Telomere shortening over 6 years is associated 
with increased subclinical carotid vascular damage and worse cardiovascular prognosis in 
the general population. J Intern Med 2015; 277(4): 478–487. 
52. Pusceddu I, Herrmann M, Kirsch SH et al. Prospective study of telomere length and 
LINE-1 methylation in peripheral blood cells: the role of B vitamins supplementation. Eur 
J Nutr. 2016;55(5):1863–73.  
53. Lee J-Y, Shin C, Baik I. Longitudinal associations between micronutrient consumption 
and leukocyte telomere length. J Hum Nutr Diet. 2017;30(2):236–43.  
54. Santhakumar AB, Battino M, Alvarez-Suarez JM. Dietary polyphenols: Structures, 
bioavailability and protective effects against atherosclerosis. Food Chem Toxicol 
2018;113:49–65. 
55. Vahid F, Zand H, Nosrat-Mirshekarlou E, Najafi R, Hekmatdoost A. The role dietary of 
bioactive compounds on the regulation of histone acetylases and deacetylases: a review. 
Gene. 2015;562(1):8–15.  
56. Lee JH, Wendorff TJ, Berger JM. Resveratrol: A novel type of topoisomerase II inhibitor. 
J Biol Chem. 2017;292(51):21011–22.  
57. Fang W-J, Wang C-J, He Yet al. Resveratrol alleviates diabetic cardiomyopathy in rats by 
improving mitochondrial function through PGC-1α deacetylation. Acta Pharmacol Sin. 
2018;39(1):59–73.  
58. Bo S, Togliatto G, Gambino R et al. Impact of sirtuin-1 expression on H3K56 acetylation 
and oxidative stress: a double-blind randomized controlled trial with resveratrol 
supplementation. Acta Diabetol. 2018;55(4):331–40. 
59. Nallasamy P, Si H, Babu PVA, et al. Sulforaphane reduces vascular inflammation in mice 
and prevents TNF-α-induced monocyte adhesion to primary endothelial cells through 
interfering with the NF-κB pathway. J Nutr Biochem. 2014;25(8):824–33.  
60. Kaufman-Szymczyk A, Majewski G, Lubecka-Pietruszewska K, Fabianowska-Majewska 
K. The Role of Sulforaphane in Epigenetic Mechanisms, Including Interdependence 
between Histone Modification and DNA Methylation. Int J Mol Sci. 2015;16(12):29732-
43.  
61. Hu J, Shen T, Xie J, et al. Curcumin modulates covalent histone modification and TIMP1 
gene activation to protect against vascular injury in a hypertension rat model. Exp Ther 
Med. 2017;14(6):5896–902.  
62. Liu D, Perkins JT, Hennig B. EGCG prevents PCB-126-induced endothelial cell 
inflammation via epigenetic modifications of NF-κB target genes in human endothelial 
cells. J Nutr Biochem. 2016;28:164–70.  
 
22 
63. Grosso G, Marventano S, Yang J et al. A comprehensive meta-analysis on evidence of 
Mediterranean diet and cardiovascular disease: Are individual components equal? Crit 
Rev Food Sci Nutr. 2017;57(15):3218–32.  
64. Rafie N, Golpour Hamedani S et al. Dietary patterns, food groups and telomere length: a 
systematic review of current studies. Eur J Clin Nutr. 2017;71(2):151–8. 
• Updated systematic review on diet and telomere length 
65. Rosato V, Temple NJ, La Vecchia C et al. Mediterranean diet and cardiovascular disease: 
a systematic review and meta-analysis of observational studies. Eur J Nutr. 2017 Nov 25. 
doi: 10.1007/s00394-017-1582-0. 
66. Arpón A, Riezu-Boj JI, Milagro FI et al. Adherence to Mediterranean diet is associated 
with methylation changes in inflammation-related genes in peripheral blood cells. J 
Physiol Biochem. 2016;73(3):445–55.  
•  Nutriepigenetic data from the PREDIMED trial 
   
 
23 
LIST OF FIGURES 
Figure 1. Sources of epigenetic modifiers: Availability of epigenetic modifiers, which are used 
for modification of histones or DNA, is determined by alterations in synthesis or catabolism of 
metabolites that are derived via glucose and fatty acid oxidation pathways, including the 
Krebs/TCA cycle and oxidative phosphorylation. Ac: Acetyl group, Me: Methyl group, P: 
Phosphoryl group, Su: Succinyl group, β-hb: β-hydroxybutyryl group, Ma: Malonyl group, *: 
Other acyl groups, DNMTs: DNA Methyl-transferases, HMTs: Histone Methyl-transferases, 
DMs: Demethylases, SAM: S-adenosylmethionine. Green color depicts modifications that 
activate transcription and red color indicates inhibitory effects.  
